4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-002379
Options or other derivatives
- CHIEF BUSINESS OFFICER AND COO acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-02-01 | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | D | ||
Loading xslF345X05/form4-02022024_100258.xml…